'Painkillers Market Will Reach $61.6 Billion in 2012' Visiongain Report Predicts

'Painkillers Market Will Reach $61.6 Billion in 2012' Visiongain Report Predicts PR Newswire LONDON, September 6, 2012 LONDON, September 6, 2012 /PRNewswire/ -- A new report by visiongain predicts that the world market for drugs to relieve pain will reach $61.6 billion for 2012. That revenue forecast appears in World Pain Relieving Drug Market 2012-2022, published in September 2012. Visiongain is a business information provider based in London, UK. The study forecasts that the overall market for pain relieving drugs will grow steadily from 2012 to 2022. The world pain-treating drug market is a high- revenue industry with a high public and healthcare profile. Market growth will be stimulated by rises in disease prevalence, ageing populations and prevalence of cancer, arthritis and diabetes. Growth of the pain treatment market will be stimulated by new drugs and reformulations of existing products from 2012 onwards. The launch of new treatments, including more-efficacious drugs, improved drug delivery and new dosing schedules, will increase revenues. Visiongain believes that increasing public awareness and the development of submarkets such as neuropathic and cancer pain treatment will be crucial to expansion of the industry and market. Dr Peter Williamson, a pharmaceutical industry analyst in visiongain, said: "Pain is a prevalent condition with huge socio-economic consequences. Many people need pain relief to complete everyday tasks.